Now that a federal appeals court in Washington, D.C., has heard arguments in Novartis and United Therapeutics’ 340B contract pharmacy lawsuits, the scene shifts to Chicago, where an appeals court will hear arguments Monday morning in Eli Lilly’s companion case.
The hearing will happen almost exactly one year after a federal district judge set aside and vacated the federal government’s May 2021 finding that Lilly’s denials of 340B ceiling prices when covered entities use contract pharmacies violate the 340B statute.
Now that a federal appeals court in Washington, D.C., has heard arguments in Novartis and United Therapeutics’ 340B contract pharmacy lawsuits, the scene shifts to Chicago, where an appeals court will hear arguments Monday morning in Eli Lilly’s companion case.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.